Year: 2026

Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in FA

Beam Global Enters LOI to Acquire European Drone Technology Company and Position Beam to Become a Vertically Integrated Drone Company.

FORM 8.3

Meet Nedap Way: the next-gen short-range reader line for secure building access.

New physically backed products broaden European investor access to decentralised financial platforms,privacy-focused digital assets and quantum-resistant architecture via standard brokerage accounts

AI Data Center Interconnect Market is segmented by Component, Technology, Interconnect Type, Deployment Model, Application, End User, and Region 2026-2035

Sampo plc, press release, 22 September 2026 at 9:20 am EEST

Sampo Oyj, lehdistötiedote, 22.9.2026 klo 9.20

VIENNA, Sept. 22, 2026 (GLOBE NEWSWIRE) — TradersYard today announced that it is making futures trading challenges its primary strategic focus, following strong growth in its futures business over recent months and the funding round announced in July 2026.

SINGAPORE, Sept. 22, 2026 (GLOBE NEWSWIRE) — Lake Energy has announced the launch of a platform for the tokenization of renewable energy Real World Assets (RWAs), enabling renewable energy infrastructure assets to be represented and managed on a blockchain-based platform.

Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026

Basel, 22 September 2026 – Roche (SIX: RO, ROP; OTCQX: RHHBY) today announced positive topline results from CT-388-104, a Phase II clinical trial evaluating enicepatide (CT-388), an investigational, once-weekly dual GLP-1/GIP receptor agonist, in adults living with type 2 diabetes (T2D) and overweight or obesity. In the study, enicepatide met both primary endpoints, delivering dose-dependent and clinically meaningful reductions in blood glucose and body weight at 48 weeks. Patients receiving the highest titrated dose (24 mg) achieved an HbA1c reduction of 2.65% (from a baseline HbA1c of 8.1%). Furthermore, 90% of patients in the 24 mg cohort reached an HbA1c level of ≤6.5% (diagnostic threshold for T2D) and 62% achieved normoglycemia (HbA1c < 5.7%), restoring blood glucose levels to a non-diabetic range. The mean weight loss at 48 weeks in the 24 mg enicepatide arm was 15.5% without a demonstrable plateau.

AI-native M&A model combines experienced deal professionals and technology to provide selected SMEs with success-fee-only transaction facilitation, broader buyer access and stronger execution support

AI-native M&A model combines experienced deal professionals and technology to provide selected SMEs with success-fee-only transaction facilitation, broader buyer access and stronger execution support

Akkodis und der hvv zeigen auf der InnoTrans 2026, wie hvv mia und KI Mobilitätsangebote intelligenter, vernetzter und nutzerfreundlicher machen.

At InnoTrans 2026, Akkodis and hvv showcase hvv mia, demonstrating how AI creates smarter, more connected and accessible mobility.

Mt laurel Township, NJ, Sept. 21, 2026 (GLOBE NEWSWIRE) — Leader’s Advantage Acquisition Corp. (Nasdaq: LEDRU) (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced today the closing of its previously announced initial public offering of 15,000,000 units. The units were sold at a price of $10.00 per unit. The Company’s units began trading on September 18, 2026 on the Nasdaq Global Market under the symbol “LEDRU”. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant is exercisable to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq Global Market under the ticker symbols “LEDR” and “LEDRW,” respectively.

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES

The Global Semiconductor Industry Size, Share, Growth, Revenue Trends & Segmentation Analysis by Component, Application, and Forecast 2026-2035.

CALGARY, ALBERTA, Sept. 21, 2026 (GLOBE NEWSWIRE) — Marksmen Energy Inc. (“Marksmen” or the “Company“) announces that it has completed the closing of its previously announced non-brokered private placement of common shares (the “Common Shares“) of Marksmen (the “Offering“). The Company issued 4,324,291 Common Shares at a price of $0.12 per Common Share for aggregate gross proceeds of $518,915.